Bioprocess

PhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free Proteomics

Retrieved on: 
Friday, September 15, 2023
Drug development, Booth, Boston Convention and Exhibition Center, Proteomics, Metabolomics, Research, ELISA, Data analysis, CELL, Convention center, Bioprocess, Meteoroid, Retail

EMERYVILLE, Calif., Sept. 15, 2023 /PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced the launch of Meteor™ chips on the IsoSpark™ platform, providing a significant advancement in high throughput, quantitative, fully automated, multiplexed bulk proteomics. ™

Key Points: 
  • ™
    The Meteor chip solution enables researchers to conduct high throughput proteomic analysis with unmatched efficiency.
  • Quantitative analysis: Each run incorporates recombinant standards run in triplicate, enabling quantitative analysis per chip on-site.
  • PhenomeX representatives will be available to provide demonstrations and discuss how the Meteor solution can revolutionize proteomics research and accelerate scientific advancements.
  • For more information about the Meteor solution on the IsoSpark platform, please visit the PhenomeX website at https://phenomex.com/products/chips/meteor/ .

BioMADE Announces Nine Projects, $18.7 Million to Advance Domestic Bioindustrial Manufacturing and DoD Sustainability Goals

Retrieved on: 
Thursday, September 14, 2023
Carbon, Fluorescence, Bioprocess engineering, U.S. Department of Defense Strategy for Operating in Cyberspace, Education, Probiotic, Poultry, Engineering, Soldier, Ethanol, Farmer, Biotechnology, Curriculum, Carbon dioxide, Polymer, Department of Defence, Innovation, Fermentation, Chicken, Synthetic biology, Domestic, Biology, Organization, Nature, Student, Oil, Manufacturing USA, STEM, Education minister, Methane, Ecosystem, Bioprocess, Molasses, Renewable energy, Natural rubber, Dietary supplement

Innovative new projects will advance sustainable food production, make DoD fleets more resilient, secure domestic supply chains for key products, and build a pipeline of trained workers.

Key Points: 
  • "These projects will help unlock the benefits of bioindustrial manufacturing for all Americans - from everyday consumers to farmers to warfighters," said Dr. Douglas Friedman, Chief Executive Officer at BioMADE.
  • Bioindustrial manufacturing harnesses the power of biology to manufacture the goods that Americans use every day.
  • By starting with feedstocks grown by American farmers, bioindustrial manufacturing creates more robust and resilient supply chains with fewer international dependencies.
  • Products such as industrial chemicals, durable fibers and fabrics, growable cement, fire-resistant composite materials, and food-grade proteins can all be produced through bioindustrial manufacturing.

Agilent Announces Thought Leader Award to Peter Neubauer

Retrieved on: 
Thursday, August 3, 2023
Health, Genetics, Other Science, Research, Science, Biotechnology, Technical University of Berlin, Big data, Engineering, Mass spectrometry, Public, Institute of technology, Automation, Agilent Technologies, Bioprocess engineering, PAT, Bioprocess, CQA, AI, NYSE, Safety, Software, Management, Fine chemical

Agilent Technologies Inc. (NYSE: A) announced that Dr. Peter Neubauer has been selected to receive a prestigious Agilent Thought Leader Award.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) announced that Dr. Peter Neubauer has been selected to receive a prestigious Agilent Thought Leader Award.
  • The Agilent Thought Leader Award will support his ongoing research into understanding and optimizing bioprocesses for difficult-to-express proteins and the development of scale-up/scale-down strategies.
  • “His important work will help the pharmaceutical industry optimize their bioprocesses and accelerate improved healthcare worldwide.”
    The Agilent Thought Leader Award program promotes fundamental scientific advances by contributing financial support, products, and expertise to the research of influential thought leaders in the life sciences, diagnostics, and chemical analysis space.
  • To learn more, visit the Agilent Thought Leader Award website.

Alternative Protein Global Investment Leader Big Idea Ventures Announces First New Protein Fund II Investments

Retrieved on: 
Wednesday, July 19, 2023
Food, Food industry, Big Idea, Euro starter kits, BIV, Software, Fermentation, Biotechnology, Nature, Investment, Bioprocess, FMP, Sport, NPF, Ecosystem, Meat, Synthetic biology, Peptide, Cryptocurrency, Fine chemical, Video game, Dairy

NEW YORK, July 19, 2023 (GLOBE NEWSWIRE) -- Big Idea Ventures, global leader in investments in the alternative protein and ingredient industry, revealed its first New Protein Fund II Paris and New York accelerator company investments today.

Key Points: 
  • NEW YORK, July 19, 2023 (GLOBE NEWSWIRE) -- Big Idea Ventures, global leader in investments in the alternative protein and ingredient industry, revealed its first New Protein Fund II Paris and New York accelerator company investments today.
  • Ten early-stage startups were selected for pre-seed investment as part of Big Idea Ventures’ bi-annual new protein accelerator program.
  • Big Idea Ventures has now made over 110 early-stage investments in the alternative protein and ingredient categories.
  • A third round of investments is being made through Big Idea Ventures’ Singapore office, and selected companies will be announced soon.

New National Directory Helps Biomanufacturers Accelerate Transition from Pilot to Commercial Scale

Retrieved on: 
Wednesday, July 19, 2023
PDT, Fermentation, Directory, EDT, Climate change, CBC, Collection, Golden LEAF Biomanufacturing Training and Education Center, Bioprocess, Publishing

The BioP2P directory is designed to bring together non-biomedical technology developers across the country with providers who have manufacturing capacity to help them scale toward commercial production.

Key Points: 
  • The BioP2P directory is designed to bring together non-biomedical technology developers across the country with providers who have manufacturing capacity to help them scale toward commercial production.
  • The directory provides information on the bioreactor capacity of each facility, the cellular platform supported, feedstocks, and downstream processing capabilities.
  • “Biomanufacturers looking to scale their production can waste precious time and money hunting down available capacity,” said Gardner.
  • “This easy-to-use directory can help companies reduce this process by several months.”
    To use the directory, go to https://biomanufacturing.net/the-directory/ .

Cambridge Innovation Institute and Barnett International Announce the Launch of the Bioprocess Professional Certification Program

Retrieved on: 
Wednesday, July 12, 2023
Good, Education, Technology Innovation Institute, Biopharma LLC, CII, BPCP, Fundamental, Certification, Implementation, Risk, Entrepreneurship, Bioprocess, Safety, Management, Nursing

Needham, Mass., July 12, 2023 -/PRNewswire-PRWeb/ -- Cambridge Innovation Institute (CII) and Barnett International announce the launch of the Bioprocess Professional Certification program (BPCP), a dedicated, Instructor-led online, module-based education and certification program designed to provide critical, non-technical support staff with 101-level bioprocess training to understand and apply core bioprocessing technologies and techniques.

Key Points: 
  • Cambridge Innovation Institute (CII) and Barnett International announce the launch of the Bioprocess Professional Certification program (BPCP), a dedicated, Instructor-led online, module-based education and certification program designed to provide critical, non-technical support staff with 101-level bioprocess training to understand and apply core bioprocessing technologies and techniques.
  • Needham, Mass., July 12, 2023 -/PRNewswire-PRWeb/ -- Cambridge Innovation Institute (CII) and Barnett International announce the launch of the Bioprocess Professional Certification program (BPCP), a dedicated, Instructor-led online, module-based education and certification program designed to provide critical, non-technical support staff with 101-level bioprocess training to understand and apply core bioprocessing technologies and techniques.
  • Offered in collaboration with The BioProcess Institute and powered by Barnett International, the BPCP program aims to provide the support, education, and training today's workers need to meet and exceed current performance expectations and be prepared for what lies ahead.
  • James Dean Vogel, Co-Founder and Instructor of the BPCP program adds, "A training program dedicated to non-scientist technical staff is long overdue.

National Bioeconomy Network Launches Webinar Series

Retrieved on: 
Wednesday, July 12, 2023
Biotechnology, Collection, Environment, Bioprocess, Biomanufacturing, Pacific Ocean

VACAVILLE, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- The BioProcess to Products (BIOP2P) Network announced it is launching the Spotlight Series, a collection of webinars featuring innovations and the innovators helping advance the bioeconomy.

Key Points: 
  • VACAVILLE, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- The BioProcess to Products (BIOP2P) Network announced it is launching the Spotlight Series, a collection of webinars featuring innovations and the innovators helping advance the bioeconomy.
  • The first installment of the Spotlight Series is scheduled for July 19th at 9:30am (Pacific) and will highlight Mark Warner, CEO of Liberation Labs.
  • Biomanufacturing will transform the U.S. economy in the next two decades, as the industry increases scale, simultaneously improving the environment and increasing national competitiveness and security.
  • Learn more about this series on the BioP2P Network website at www.biomanufacturing.net
    To register for the free event, go to https://www.linkedin.com/events/biop2pspotlightseries7082423951699677184...

Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing

Retrieved on: 
Monday, June 5, 2023
Vaccine, WAT, Senior, Waters, Software, AAV, Aggregation, Sartorius, Bioprocess, Waters Corporation, A-DNA, NYSE, Nanwang water division system, Fine chemical, Hook effect

MILFORD, Mass. and GOETTINGEN, Germany, June 5, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics. Software and hardware integrations between the Waters™ PATROL™ UltraPerformance Liquid Chromatography (UPLC™) Process

Key Points: 
  • Integration of Sartorius' process scale multi-column chromatography with Waters' process analytical technology to provide robust analytical data for downstream biomanufacturing of mAbs, recombinant proteins, vaccines, and other biologics.
  • Integrated solution to deliver vital analytical data in days, not weeks – and to reduce waste and help lower drug production costs.
  • Bioprocess scientists will be able to check product quality closer to the process, saving weeks of production time.i
    MILFORD, Mass.
  • and GOETTINGEN, Germany, June 5, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics.

Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing

Retrieved on: 
Monday, June 5, 2023
Vaccine, WAT, Senior, Waters, Software, AAV, Aggregation, Sartorius, Bioprocess, Waters Corporation, A-DNA, NYSE, Nanwang water division system, Fine chemical, Hook effect

MILFORD, Mass. and GOETTINGEN, Germany, June 5, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics. Software and hardware integrations between the Waters™ PATROL™ UltraPerformance Liquid Chromatography (UPLC™) Process

Key Points: 
  • Integration of Sartorius' process scale multi-column chromatography with Waters' process analytical technology to provide robust analytical data for downstream biomanufacturing of mAbs, recombinant proteins, vaccines, and other biologics.
  • Integrated solution to deliver vital analytical data in days, not weeks – and to reduce waste and help lower drug production costs.
  • Bioprocess scientists will be able to check product quality closer to the process, saving weeks of production time.i
    MILFORD, Mass.
  • and GOETTINGEN, Germany, June 5, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics.

Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region

Retrieved on: 
Friday, May 19, 2023
Biotechnology, Commercial Building & Real Estate, Manufacturing, Construction & Property, Other Health, Health, Pharmaceutical, Other Science, Medical Devices, Other Manufacturing, Science, Yee, Vaccine, Molecular biology, Senior, Education, Good manufacturing practice, Chromatography, Multimedia, Research, Thermo Fisher Scientific, Mass spectrometry, Norwich Pharma Services, CGMP, EDB, Bioprocess, The Singapore Economic Review, Economic Development Board, Airline, Management, Pharmaceutical industry, Fine chemical, Health care, Marketing

“Thermo Fisher Scientific's fill-finish manufacturing facility will enable end-to-end vaccine manufacturing to be carried out in Singapore.

Key Points: 
  • “Thermo Fisher Scientific's fill-finish manufacturing facility will enable end-to-end vaccine manufacturing to be carried out in Singapore.
  • This strategic investment in Singapore complements new research capabilities at Thermo Fisher Scientific's Customer Experience Center and Bioprocess Design Center, two other operational lab facilities that showcase the latest bioprocessing, life science, and analytical technologies.
  • Together, these sites allow Thermo Fisher to better enable customers to accelerate their research, as well as develop and commercialize new medicines and vaccines in the Asia-Pacific market.
  • In total, over 2,000 company employees are contributing to Singapore’s evolution as a biomedical hub in the Asia-Pacific region.